Collagen Solutions (COS)

 

COS Share PerformanceMore

52 week high6.4500 25/04/17
52 week low2.3480 30/01/18
52 week change -1.7050 (-29.65%)
4 week volume7,499,948 28/01/18
price4.0450
price date1519401079
close3.7500

Media for (COS)

Latest NewsMore

Director Deals - Collagen Solutions Plc (COS)

Malcolm Gillies, Non Executive Director, bought 500,000 shares in the company on the 21st February 2018 at a price of 3.30...

Director Deals - Collagen Solutions Plc (COS)

Hilary Spence, Director, bought 30,817 shares in the company on the 21st February 2018 at a price of 3.18p. The Director now...

Director/PDMR Shareholding

RNS Number: 6804F Collagen Solutions PLC 22 February 2018 22 February 2018 Collagen Solutions plc ("Collagen Solutions", the "Company" or the "Group") Director/PDMR Shareholding The Company today announces that on 21 February 2018 the following share purchases were made. Malcolm Gillies, Non-Executive Director, purchased 500,000 ordinary shares o...

Collagen Solutions gets positive test results for knee implant

Collagen Solutions said it had achieved successful results from an eight-year extension clinical study of 15 patients who rece...

Positive results of ChondroMimetic Clinical Study

RNS Number: 4560F Collagen Solutions PLC 21 February 2018 21 February 2018 Collagen Solutions Plc (the "Company") Positive Eight-Year Results of ChondroMimetic Cartilage Repair Clinical Study Study confirms sustained long-term repair of knee cartilage and improved clinical symptoms Collagen Solutions Plc (AIM: COS), the developer and manufacturer of m...

China update

RNS Number: 9337E Collagen Solutions PLC 15 February 2018 15 February 2018 Collagen Solutions Plc (the "Company" or the "Group") China Update Collagen Solutions plc (AIM: COS), the developer and manufacturer of medical grade collagen and tissue components for use in regenerative medicine, including orthopaedic, dental, wound care, and cardiovascular app...

Investor presentation

RNS Number: 9665D Collagen Solutions PLC 06 February 2018 Collagen Solutions Plc (the "Company" or the "Group") London Investor Symposium Monday 26 February 2018 Collagen Solutions plc (AIM: COS), the developer and manufacturer of medical grade collagen and tissue components for use in regenerative medicine applications including orthopaedics, denta...

Collagen confirms ChondroMimetic deal

Collagen Solutions has announced its first partnering deal for ChondroMimetic with a South Korean partner, Insung Med...

Fundamental DataMore

EPS-0.95
Dividend yield0 %

Latest discussion posts More

  • Video: COS presentation at Hardman

    Investor presentation by Collagen Solutions CEO Jamal Rushdy at the Hardman & Co?s Investors Forum 20th September ...
    28-Sep-2017
    piw
  • Panmure Gordon note - Research Tree

    Read Panmure Gordon & Co's note on COLLAGEN SOLUTIONS PLC (COS), out this morning, by visiting https://www.research-tree.com/company/GB00B94T6Y14 "Collagen Solutions has ...
    3-May-2016
    FoxRed
  • Panmure Gordon note - Research Tree

    Read Panmure Gordon & Co's note on COLLAGEN SOLUTIONS, out this morning, by visiting https://www.research-tree.com/company/GB00B94T6Y14 "Collagen Solutions announced yesterday ...
    27-Apr-2016
    FoxRed

Users' HoldingsMore

Users who hold Collagen Solutions also hold..

Codes & Symbols

ISINGB00B94T6Y14
SymbolsCOS, LSE:COS, COS.L, COS:LN, LON:COS, XLON:COS

Join interactive investor

  • £22.50 fixed quarterly charge includes £22.50 in trading credits
  • £10 per trade or £6 for frequent traders
  • No % platform fees
  • £1 per trade for regular investment or dividend reinvestment

Open an account